{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T05:19:12Z","timestamp":1764652752625,"version":"3.46.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Ophthalmol."],"abstract":"<jats:p>Rhino-orbital cerebral mucormycosis (ROCM) is a rare, but potentially fatal opportunistic infection due to a fungus of the Mucorales sp. that involves infiltration of the sinuses, orbits, and central nervous system. Orbital exenteration (OE) is reserved for severe cases refractory to initial antifungal treatment and endoscopic sinus debridement, though there is currently no consensus on the ideal timing of OE and its impact on infection progression and survival. In this case series, we present three cases of similar, extensive ROCM that were candidates for OE after initial medical and surgical management with variable outcomes. We discuss that undergoing OE does not necessarily correlate with survival after ROCM infection and that the decision to proceed with exenteration should be personalized based on the status of a patient's comorbidities and the nature and extent of infectious spread. Globe-sparing OE may serve as a viable alternative for patients with localized, late-stage infection or reversible ROCM risk factors given vision preservation and less postoperative disfigurement with possibly comparable efficacy.<\/jats:p>","DOI":"10.3389\/fopht.2025.1689076","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T05:14:09Z","timestamp":1764652449000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the role of orbital exenteration in survival among patients with severe rhino-orbital cerebral mucormycosis: a case series"],"prefix":"10.3389","volume":"5","author":[{"given":"Shaili S.","family":"Davuluru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill A.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandy","family":"Zhang-Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2012.01.003","article-title":"Cerebro-rhino orbital mucormycosis: an update","volume":"5","author":"Wali","year":"2012","journal-title":"J Infect Public Health"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e41010","DOI":"10.7759\/cureus.41010","article-title":"Orbital mucormycosis: understanding the deadly fungus sweeping the globe","volume":"15","author":"Farooq","year":"2023","journal-title":"Cureus"},{"key":"B3","unstructured":"Mucormycosis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S366067","article-title":"Exenterate or not: A simple proposed management algorithm for mucormycosis during the era of COVID-19 in a tertiary eye care center in Egypt","volume":"16","author":"Shabana","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000002030","article-title":"Clinical presentations, management and outcomes of rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19: A multi-centric study","volume":"37","author":"Dave","year":"2021","journal-title":"Ophthalmic Plast Reconstructive Surg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4103\/IJO.IJO_2543_22","article-title":"Survival benefit of exenteration in COVID-19-associated rhino-orbital mucormycosis","volume":"72","author":"Raj","year":"2024","journal-title":"Indian J Ophthalmol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0039-6257(05)80041-4","article-title":"Survival factors in rhino-orbital-cerebral mucormycosis","volume":"39","author":"Yohai","year":"1994","journal-title":"Surv Ophthalmol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/coa.13175","article-title":"A meta-analysis of survival factors in rhino-orbital-cerebral mucormycosis-has anything changed in the past 20 years","volume":"43","author":"Vaughan","year":"2018","journal-title":"Clin Otolaryngol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000394","article-title":"Invasive fungal sinusitis: treatment of the orbit","volume":"28","author":"Kalin-Hajdu","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s12070-018-1293-8","article-title":"Orbital exenteration in rhino-orbito-cerebral mucormycosis: A prospective analytical study with scoring system","volume":"71","author":"Shah","year":"2019","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ajo.2021.05.025","article-title":"Outcomes of a modified treatment ladder algorithm using retrobulbar amphotericin B for invasive fungal rhino-orbital sinusitis","volume":"237","author":"Ashraf","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000001357","article-title":"Invasive fungal sinusitis: risk factors for visual acuity outcomes and mortality","volume":"35","author":"Hirabayashi","year":"2019","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/lary.23912","article-title":"Survival outcomes in acute invasive fungal sinusitis: A Systematic Review and Quantitative Synthesis of Published Evidence","volume":"123","author":"Turner","year":"2013","journal-title":"Laryngoscope"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-312688","article-title":"Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis","volume":"103","author":"Kashkouli","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/01.iop.0000225418.50441.ee","article-title":"Indications for orbital exenteration in mucormycosis","volume":"22","author":"Hargrove","year":"2006","journal-title":"Ophthalmic Plast Reconstructive Surg"},{"key":"B16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1001\/jamaophthalmol.2021.5201","article-title":"Cumulative mortality and factors associated with outcomes of mucormycosis after COVID-19 at a multispecialty tertiary care center in India","volume":"140","author":"Choksi","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejim.2022.03.008","article-title":"Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study","volume":"100","author":"Cag","year":"2022","journal-title":"Eur J Intern Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1186\/s12879-024-09755-6","article-title":"Risk Factors of COVID-19 associated mucormycosis in Iranian patients: a multicenter study","volume":"24","author":"Eshraghi","year":"2024","journal-title":"BMC Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"16088","DOI":"10.1038\/s41598-025-98926-9","article-title":"Survival and prognostic factors in rhino-orbito-cerebral mucormycosis: A 3-year cohort study","volume":"15","author":"Zia","year":"2025","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000002256","article-title":"Retrobulbar injection of amphotericin B in patients with COVID-19 associated orbital mucormycosis: A systematic review","volume":"38","author":"Sharifi","year":"2022","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-022-02591-0","article-title":"Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19","volume":"43","author":"Shakrawal","year":"2023","journal-title":"Int Ophthalmol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/11206721251361276","article-title":"Orbit management sans exenteration with retrobulbar injection of amphotericin-B in Rhinoorbitocerebral mucormycosis: Impact on survival","author":"Karat","year":"2025","journal-title":"Eur J Ophthalmol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1080\/01676830.2023.2186435","article-title":"Transcutaneous retrobulbar amphotericin B for rhino-orbital-cerebral mucormycosis: a multi-center retrospective comparative study","volume":"43","author":"Dallalzadeh","year":"2024","journal-title":"Orbit"},{"key":"B24","first-page":"4056","article-title":"Surgical outcomes of a novel lid-sparing orbital exenteration technique in rhino-orbital cerebral mucormycosis","volume":"64","author":"Mukit","year":"2023","journal-title":"Invest. Ophthalmol Vis Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/00494755211041865","article-title":"Total eyelid complex sparing orbital exenteration for mucormycosis","volume":"52","author":"Agarwal","year":"2022","journal-title":"Trop Doct"}],"container-title":["Frontiers in Ophthalmology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2025.1689076\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T05:14:11Z","timestamp":1764652451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2025.1689076\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":25,"alternative-id":["10.3389\/fopht.2025.1689076"],"URL":"https:\/\/doi.org\/10.3389\/fopht.2025.1689076","relation":{},"ISSN":["2674-0826"],"issn-type":[{"type":"electronic","value":"2674-0826"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"article-number":"1689076"}}